Usage: *For complete product information, please review the full prescribing information in the manufacturer package insert. Galliprant tablets should be given orally as directed by your veterinarian. Please consult your veterinarian before making any changes or discontinuing the prescribed dosing schedule. This medication can be given with or without food. If your pet vomits or appears unwell after receiving a dose on an empty stomach, give future doses with food or a small treat. If vomiting continues, contact your veterinarian. Ensure your pet always has access to fresh, clean drinking water while taking this medication. Manufacturer Dosage and Administration: Carefully consider the potential benefits and risks of GALLIPRANT and other treatment options before deciding to use GALLIPRANT. Use the lowest effective dose for the shortest duration consistent with individual response. The dose of GALLIPRANT (grapiprant tablets) is 0.9 mg⁄lb (2 mg⁄kg) once daily. The dosage should be calculated in half–tablet increments. Dogs less than 8 lbs. (3.6 kg) cannot be accurately dosed. For dogs larger than 150 lbs. (68 kg), use a combination of whole and half–tablets to achieve the appropriate dose. Only the 20 mg and 60 mg tablets of GALLIPRANT are scored. The 100 mg tablet is not scored and should not be broken in half. Breaking the 100 mg tablet in half will not guarantee that half of the active ingredient is contained within each half of the tablet.

Missed Doses: Administer the dose as soon as possible. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not give more medication than prescribed or two doses at once.

Side Effects: The most common side effects of this medication are vomiting, diarrhea or soft stools, decreased appetite, and lethargy. Contact your veterinarian immediately if your pet has complete loss of appetite; extreme fatigue, weakness, or lack of coordination; seizures; extreme behavioral changes (e.g., depression, restlessness); significant changes in activity⁄energy level, urinary habits, or fluid intake; vomiting that is severe, appears bloody, or has a
"coffee grounds" appearance; black, tarry, or bloody stools; pale gums; or if you notice yellowing of the skin, whites of the eyes, and⁄or gums. Notify your veterinarian if your pet experiences any of the effects described above, or if you notice any other side effects that are persistent or troublesome. If you notice anything unusual, please consult your veterinarian.

Precautions: *For complete product information including warnings and precautions, please refer to the manufacturer package insert. For oral use in dogs only– not for use in humans. Keep this and all medications out of reach of children and pets. Consult a physician in case of accidental ingestion by humans. Keep GALLIPRANT in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. All dogs should undergo a thorough history and physical examination before the initiation of NSAID therapy. Appropriate laboratory tests to establish hematological and serum biochemical baseline data prior to and periodically during administration of any NSAID is recommended. Do not administer GALLIPRANT in conjunction with any other oral or injectable NSAID or corticosteroid. Consider appropriate washout times when switching from GALLIPRANT to another NSAID (or vice versa) or when switching from corticosteroid use to GALLIPRANT use. As a class, NSAIDs may be associated with gastrointestinal, renal, and hepatic toxicity. Sensitivity to drug–associated adverse events varies with the individual patient. Dogs that have experienced adverse reactions from one NSAID may experience adverse reactions from another NSAID. Patients at greatest risk for adverse events are those that are dehydrated, on concomitant diuretic therapy, or those with existing renal, cardiovascular, and⁄or hepatic dysfunction. The use of GALLIPRANT in dogs with cardiac disease has not been studied. If GALLIPRANT is used long&ndash